Pharma-Bio Serv (PBSV) Payout Ratio (2019 - 2026)

Pharma-Bio Serv (PBSV) has reported Payout Ratio for 8 consecutive years, with 7.37 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Payout Ratio fell 59.13% year-over-year to 7.37; the trailing twelve-month figure through Jan 2026 stood at 0.03 (down 474.77% YoY), and the FY2025 full-year result was 17.12, down 672.99% from the prior year.
• Payout Ratio rose to 7.37 in Q2 2026 per PBSV's latest filing, from 52.27 in the prior quarter.
• Across five years, Payout Ratio topped out at 18.04 in Q2 2025 and bottomed at 201.49 in Q1 2025.
• Historically, Payout Ratio has averaged 25.08 across 5 years, with a median of 4.26 in 2023.
• The widest YoY moves for Payout Ratio: up 323.94% in 2025, down 3067.23% in 2025.
• Over 5 years, Payout Ratio stood at 7.18 in 2022, then tumbled by 40.7% to 4.26 in 2023, then slumped by 289.08% to 8.05 in 2024, then soared by 323.94% to 18.04 in 2025, then tumbled by 59.13% to 7.37 in 2026.
• According to Business Quant data, Payout Ratio over the past three periods registered 7.37, 52.27, and 18.04 for Q2 2026, Q1 2026, and Q2 2025 respectively.